Aethlon Medical Inc (AEMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
37
About the Report
About the Report
Summary
Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company's lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, which is an enzyme linked lectin specific assay to identify and quantify the presence of exosomes in HIV, HCV and tuberculosis. The company is also developing a medical device under the DARPA Sepsis program. Aethlon harnesses its ADAPT system to develop infrastructure of dialysis machines and CRRT systems in hospitals and clinics. Aethlon Medical is headquartered in San Diego, California, the US.
Aethlon Medical Inc (AEMD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Aethlon Medical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aethlon Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11
Equity Offering 12
Aethlon Medical Raises USD6 Million in Public Offering of Units 12
Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 13
Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For USD 1.8 Million 14
Debt Offering 15
Aethlon Medical Completes Private Placement Of 5% Original Issue Discount Unsecured Convertible Debentures For USD 1.8 Million 15
Aethlon Medical Inc-Key Competitors 16
Aethlon Medical Inc-Key Employees 17
Aethlon Medical Inc-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 08, 2018: Aethlon Medical announces first quarter fiscal year 2019 results 19
Jun 08, 2018: Aethlon Medical Reports Fiscal 2018 Financial Results 20
Feb 01, 2018: Aethlon Medical Announces Fiscal 2018 Third Quarter Results 22
Nov 02, 2017: Aethlon Medical Announces Fiscal 2018 Second Quarter Results 24
Aug 10, 2017: Aethlon Medical Announces Fiscal 2018 First Quarter Results 25
Jun 28, 2017: Aethlon Medical Announces Fiscal 2017 Results 27
Feb 10, 2017: Aethlon Medical Announces Fiscal 2017 Third Quarter Results 29
Corporate Communications 31
Jun 25, 2018: Aethlon Medical Names Guy Cipriani As Board Director 31
Jan 10, 2018: Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors 32
Nov 09, 2017: Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors 33
Government and Public Interest 34
Apr 24, 2017: Aethlon Medical Releases Shareholder Update 34
Other Significant Developments 35
Jan 11, 2017: Aethlon Medical Provides Clinical Study Update and a Review of 2016 Accomplishments 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aethlon Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aethlon Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11
Aethlon Medical Raises USD6 Million in Public Offering of Units 12
Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 13
Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For USD 1.8 Million 14
Aethlon Medical Completes Private Placement Of 5% Original Issue Discount Unsecured Convertible Debentures For USD 1.8 Million 15
Aethlon Medical Inc, Key Competitors 16
Aethlon Medical Inc, Key Employees 17
Aethlon Medical Inc, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.